DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Dr Reddys Share Price Live Updates: Dr. Reddys Stock Details

Economic Times 3 hrs ago·11 Sept 2026, 2:47 am

Dr. Reddy's Laboratories is currently in the spotlight as investors track the latest developments surrounding the company. The focus is on understanding the factors influencing the stock's movement and the broader implications for the pharmaceutical sector.

For investors, this news highlights the importance of staying updated on corporate actions, market trends, and regulatory changes that can impact a company's valuation. It serves as a reminder to evaluate the company's fundamentals alongside market sentiment.

Moving forward, investors should keep an eye on official announcements from the company, quarterly earnings reports, and any updates on regulatory approvals or product launches. These factors will be key in determining the stock's future trajectory.